N-acetyl-transferase phenotype and risk for preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 193, Issue 3, 2005, Pages 797-802

  Zusterzeel, Petra L M ^a   Te Morsche, René H M ^a   Raijmakers, Maarten T M ^a   Roes, Eva Maria ^a   Peters, Wilbert H M ^a   Steegers Theunissen, Régine P M ^a,b   Steegers, Eric A P ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biotransformation; HELLP syndrome; N acetyltransferase; Preeclampsia

Indexed keywords

ACYLTRANSFERASE; CAFFEINE; CYTOCHROME P450;

ACETYLATOR PHENOTYPE; ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HELLP SYNDROME; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; CAFFEINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELLP SYNDROME; HUMANS; PHENOTYPE; PRE-ECLAMPSIA; PREGNANCY; SMOKING;

EID: 24344454760     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.01.012     Document Type: Article

References (22)

1. G.A. Higgs, and J.R. Vane Inhibation of cyclo-oxygenase and lipoxygenase Br Med Bull 39 1983 265 270
2. J. Uotila, R. Tuimala, T. Aarnio, and K. Pyykko Erythrocyte glutathione peroxidase activity in hypertensive complications of pregnancy Gynecol Obstet Invest 29 1990 259 262
3. C.A. Hubel, A.V. Kozlov, B.E. Kagan, R.W. Evans, S.T. Davidge, and M.K. McLaughlin Decreased transferrin and increased transferrin saturation in sera of women with preeclampsia: implications for oxidative stress Am J Obstet Gynecol 175 1996 692 700
4. E.M. Roes, M.T.M. Raijmakers, P.L.M. Zusterzeel, M.F.C.M. Knapen, W.H.M. Peters, and E.A.P. Steegers Deficient detoxifying capacity in the pathophysiology of preeclampsia Med Hypotheses 55 2000 415 418
5. L.W. Wormhoudt, J.N. Commandeur, and N.P.E. Vermeulen Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity Crit Rev Toxicol 29 1999 59 124
6. M.F.C.M. Knapen, P.L.M. Zusterzeel, W.H.M. Peters, and E.A.P. Steegers Glutathione and glutathione-related enzymes in reproduction: a review Eur J Obstet Gynecol Reprod Biol 82 1999 171 184
7. J. Seidegard, and G. Ekstrom The role of human glutathione S-transferase and epoxide hydrolases in the metabolism of xenobiotics Environ Health Perspect 105 Suppl 4 1997 791 799
8. P.L.M. Zusterzeel, W. Visser, W.H.M. Peters, J.M.W.M. Merkus, W.L.D.M. Nelen, and E.A.P. Steegers Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia Obstet Gynecol 95 2000 50 54
9. P.L.M. Zusterzeel, W.H.M. Peters, W. Visser, K.J.M. Hermsen, J.M.W.M. Merkus, and E.A.P. Steegers A polymorphism in microsomal epoxide hydrolase gene is associated with preeclampsia J Med Genet 38 2001 234 237
10. C.M. King, S.J. Land, R.F. Jones, M. Debiec-Rychter, M.S. Lee, and C.Y. Wang Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines Mutat Res 376 1997 123 128
11. H. Okkels, T. Sigsgaard, H. Wolf, and H. Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol Biomarkers Prev 6 1997 225 231
12. H. Baranova, M. Canis, T. Ivaschenko, E. Albuisson, R. Bothorishvilli, and V. Baranov Possible involvement of arylamine N-acetyltransferase 2, glutathione S-transferase M1 and T1 genes in the development of endometriosis Mol Human Reprod 5 1999 636 641
13. A. Hirvonen Polymorphic NATs and cancer predisposition IARC Sci Publ 148 1999 251 270
14. L. Le Marchant, L. Sivamaran, A.A. Franke, L.J. Custer, L.R. Wilkens, and A.F. Lau Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies? Cancer Epidemiol Biomarkers Prev 5 1996 449 455
15. I.A.L.M. Van Rooy, P.M.W. Groenen, M. van Drongelen, R.H.M. te Morsche, W.H.M. Peters, and R.P.M. Steegers-Theunissen Orofacial clefts and spina bifida: N-acetyltransferase phenotype, maternal smoking, and medication use Teratology 66 2002 260 266
16. B.K. Tang, D. Kadar, L. Qian, J. Iriah, J. Yip, and W. Kalow Caffeine as a metabolic probe: validation of its use for acetylator phenotyping Clin Pharmacol Ther 49 1991 648 657
17. I. Cascorbi, N. Drakoulis, J. Brockmöller, A. Mauer, K. Sperling, and I. Rots Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity Am J Hum Genet 57 1995 581 592
18. G. Loverro, P. Greco, F. Capuano, G. Carone, and L. Selvaggi Lipoperoxidation and antioxidant enzymes activity in pregnancy complicated with hypertension Eur J Obstet Genecol Reprod Biol 70 1996 123 127
19. Y. Wang, and S.W. Walsh Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas J Soc Gynecol Investig 3 1996 179 184
20. P.L.M. Zusterzeel, W.H.M. Peters, M.A.H. de Bruyn, J.M.W.M. Merkus, and E.A.P. Steegers Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies Obstet Gynecol 94 1999 1033 1038
21. K. Vistisen, H.E. Poulsen, and S. Loft Foreign compounds metabolism capacity in man measured from metabolites of dietary caffeine Carcinogenesis 13 1992 1561 1568
22. N. Rothman, R.B. Hayes, W. Bi, N. Caporosa, F. Broly, and R.L. Woosley Correlation between N-